JTO Insights

About JTO Insights

Welcome to JTO Insights, the official podcast of the International Association for the Study of Lung Cancer (IASLC) Journal of Thoracic Oncology (JTO). In each episode, hosts Dr. Alex Adjei and Dr. Tom John deliver concise, accessible insights from the latest JTO research. Each episode features expert discussions with authors, highlighting key studies, clinical implications, and future directions in thoracic oncology. Designed for clinicians, researchers, and healthcare professionals, JTO Insights helps you quickly stay informed on the most impactful advances in the field. Subscribe now so you don’t miss an episode and visit jto.org for full articles and additional research.

Publisher

JTO Insights

Category

science

Language

en

Explicit

No

First episode

3 Apr 2026

Latest episode

8 Oct 2026

Latest episodes

14 episodes in the feed.

1. 

   8 Oct 2026

   JTO - September 2026 (1)

   JTO - September 2026 (1) by JTO Insights

2. 

   24 Sept 2026

   JTO Insights: 20 Years of Progress in Immunotherapy

   In this episode of JTO Insights, recorded at the 2026 World Conference on Lung Cancer, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host the corresponding author of an article published in the JTO 20th Anniversary Series. Dr. Karen Reckamp, Professor of Medicine, Division of Medical Oncology at Cedars Sinai Medical Center, joins us to discuss their article, "The Evolution of Immunotherapy Revolution in Lung Cancer: a 20 Year Perspective." Recommended Reading: 1. The Evolution of Immunotherapy Revolution in Lung Cancer: a 20 Year Perspective: https://www.jto.org/article/S1556-0864(26)00410-7/fulltext 2. JTO 20th Anniversary Series www.jto.org/content/20thAnniversarySeries Hosts: Alex A. Adjei, MD, PhD, FACP Editor-in-Chief, Journal of Thoracic Oncology Chief, Taussig Cancer Institute, Cleveland Clinic, Ohio, United States. Thomas John, MBBS, PhD Associate Editor, Journal of Thoracic Oncology Deputy Director, Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. Guest : Karen L. Reckamp, MD, MS Department of Medicine, Division of Medical Oncology Cedars Sinai Medical Center Los Angeles, California.

3. 

   10 Sept 2026

   JTO Insights: September 2026

   JTO Insights: September 2026 by JTO Insights

4. 

   27 Aug 2026

   JTO Insights: 20 Years of Progress in Patient Advocacy

   Episode Summary Episode 10: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host the corresponding author of an article published in the JTO 20th Anniversary Series. Dr. Jean-Louis Pujol, Professor at Montpellier School of Medicine of Montpellier University in France, joins us to discuss their article, "Lung cancer patient advocacy progress and new challenges since 2006". Recommended Reading: 1. Lung cancer patient advocacy progress and new challenges since 2006 https://www.jto.org/article/S1556-0864(26)00345-X/fulltext 2. JTO 20th Anniversary Series https://www.jto.org/content/20thAnniversarySeries Hosts: Alex A. Adjei, MD, PhD, FACP Editor-in-Chief, Journal of Thoracic Oncology Chief, Taussig Cancer Institute, Cleveland Clinic, Ohio, United States. X: @DrAlexAdjei LinkedIn: https://www.linkedin.com/in/alex-adjei-9434bb16b/ Thomas John, MBBS, PhD Associate Editor, Journal of Thoracic Oncology Deputy Director, Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. X: @TommyJohn00; Bluesky: @drtomjohn@bsky.social LinkedIn: https://www.linkedin.com/in/tom-john-1084ab362/ Guest : Jean-Louis Pujol, MD, PhD Professor Montpellier University Montpellier School of Medicine Montpellier, France

5. 

   13 Aug 2026

   JTO Insights: August 2026

   Episode 9: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John speak with authors of two articles published in the August issue of the Journal of Thoracic Oncology. Michael J. Grant, MD, Assistant Professor of Medicine in the Section of Medical Oncology at Yale School of Medicine in New Haven, Connecticut, discusses “ERBB2-Activating Mutations and Co-Occurring Genomic Alterations Contribute to Disease Heterogeneity in Patients With ERBB2-Mutant Lung Cancer.” Christian Rolfo, MD, PhD, Division Director of Medical Oncology and Associate Director for Early Phase Clinical Trials at The James Comprehensive Cancer Center, The Ohio State University, discusses “Molecular Profiling Across 80,000 Patients With Lung Cancer.” Recommended Reading: 1. ERBB2-Activating Mutations and Co-Occurring Genomic Alterations Contribute to Disease Heterogeneity in Patients With ERBB2-Mutant Lung Cancer https://www.jto.org/article/S1556-0864(26)00161-9/fulltext 2. Molecular Profiling Across 80,000 Patients With Lung Cancer https://www.jto.org/article/S1556-0864(26)00148-6/fulltext 3. August 2026, Volume 21Issue 8 https://www.jto.org/issue/S1556-0864(26)X2007-X

6. 

   30 Jul 2026

   JTO Insights: 20 Years of Advances in Imaging and Interventional Radiology

   Episode Summary Episode 8: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John highlight two articles published in the JTO 20th Anniversary Series. Dr. David Ryan of Royal Brompton & Harefield Hospitals, London, joins us to discuss their article, "Interventional Radiology and Thoracic Oncology: 20 Years of Innovation". Also featured in this episode is the article “Advances in Radiological Imaging for Thoracic Oncology: A 20-Year Perspective" by Drs. Jeremy Erasmus and Ioannis Vlahos. Recommended Reading: 1. Interventional Radiology and Thoracic Oncology: 20 Years of Innovation: https://www.jto.org/article/S1556-0864(26)00343-6/fulltext 2. Advances in Radiological Imaging for Thoracic Oncology: A 20-Year Perspective: https://www.jto.org/article/S1556-0864(26)00016-X/fulltext 3. JTO 20th Anniversary Series: https://www.jto.org/content/20thAnniversarySeries

7. 

   16 Jul 2026

   JTO Insights: July 2026

   Episode 7: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host Dr. Masahiro Torasawa, the corresponding author of "Tumor Inflammation–Associated Neurotoxicity Masquerading as Severe Immune Effector Cell–Associated Neurotoxicity Syndrome in a Patient With SCLC Treated With Tarlatamab: A Case Report" published in the Journal of Thoracic Oncology July issue. Also featured in this episode is the article "TTF-1 Expression in Lung Adenocarcinoma: Clinicopathologic, Genomic, and Immunophenotypic Correlates and Outcomes to Immunotherapy-Based Treatments and KRASG12C Inhibitors" by Di Federico et al. Recommended Reading 1. Tumor Inflammation–Associated Neurotoxicity Masquerading as Severe Immune Effector Cell–Associated Neurotoxicity Syndrome in a Patient With SCLC Treated With Tarlatamab: A Case Report: https://www.jto.org/article/S1556-0864(26)00102-4/fulltext 2. TTF-1 Expression in Lung Adenocarcinoma: Clinicopathologic, Genomic, and Immunophenotypic Correlates and Outcomes to Immunotherapy-Based Treatments and KRASG12C Inhibitors: https://www.jto.org/article/S1556-0864(26)00063-8/fulltext 3. This month’s issue: https://www.jto.org/issue/S1556-0864(26)X2006-8

8. 

   25 Jun 2026

   JTO Insights: 20 Years of Advances in Pulmonology

   Episode 6: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host the corresponding author of an article published in the JTO 20th Anniversary Series. Dr. Emily Stone, a Conjoint Professor at the UNSW Sydney Faculty of Medicine and a consultant respiratory physician at St Vincent's Hospital, Sydney, joins us to discuss their article "Advances in Diagnosis - Pulmonology". Recommended Reading 1. Advances in Diagnosis – Pulmonology: https://www.jto.org/article/S1556-0864(26)00101-2/fulltext 2. JTO 20th Anniversary Series: https://www.jto.org/content/20thAnniversarySeries

9. 

   11 Jun 2026

   JTO Insights: June 2026

   Episode 5: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host authors of two articles published in the Journal of Thoracic Oncology June issue. Dr. Natasha B. Leighl, Head of Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre, joins us to discuss their article "Identifying patients with high-risk stage I NSCLC using tumor-informed plasma ctDNA"; and Dr. Gabriella Sozzi, who leads the Experimental Oncology Department and Epigenomics & Biomarkers of Solid Tumors Unit at National Cancer Institute in Milan, Italy, joins to discuss their article, "Clinical Value of Combining Molecular and Immune Blood Tests to Safely Reduce False Positives in Low-Dose CT Lung Cancer Screening". Recommended Reading: 1. Identifying patients with high-risk stage I NSCLC using tumor-informed plasma ctDNA: https://www.jto.org/article/S1556-0864(26)00098-5/fulltext 2. Clinical Value of Combining Molecular and Immune Blood Tests to Safely Reduce False Positives in Low-Dose CT Lung Cancer Screening: https://www.jto.org/article/S1556-0864(26)00067-5/fulltext 3. This month’s JTO issue: https://www.jto.org/issue/S1556-0864(26)X2004-4

10. 

    28 May 2026

    JTO Insights: 20 Years of Advances in Screening & Surgery

    In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host authors of two articles published in the JTO 20th Anniversary Series. Dr. Stephen Lam, Director of the MDS-Rix Early Lung Cancer Detection and Translational Research Program at BC Cancer Research Institute, joins us to discuss their article, “A Game-Changing 20 Years: Progress and Future Directions in Lung Cancer Screening"; and Dr. Paul Van Schil, Consultant Thoracic Surgeon at Antwerp University Hospital, joins to discuss their article, "Journal of Thoracic Oncology 20th Anniversary Series - Surgery". Recommended Reading: JTO 20th Anniversary Series: https://www.jto.org/content/20thAnniversarySeries A Game-Changing 20 Years: Progress and Future Directions in Lung Cancer Screening: https://www.jto.org/article/S1556-0864(25)02935-1/fulltext Journal of Thoracic Oncology 20th Anniversary Series - Surgery: https://www.jto.org/article/S1556-0864(25)02938-7/fulltext

11. 

    14 May 2026

    JTO Insights: May 2026

    In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host authors of two articles published in the May issue of the Journal of Thoracic Oncology. Dr. Bonnie Ky, Founder’s Professor of Cardio-Oncology at the Perelman School of Medicine, University of Pennsylvania, discusses their article “Changes in Cardiac Function in Patients Receiving Radiation Therapy for Lung Cancer”; and Dr. David Planchard, Head of Thoracic Group at Gustave Roussy, discusses their article “Trastuzumab Deruxtecan in Patients with HER2-Overexpressing Non-Small Cell Lung Cancer: Results From Part 1 of the Open-label, Multicenter, Phase 1b DESTINY-Lung03 Trial.” Guests: Bonnie Ky, MD, MSCE Founders Professor of Cardio-Oncology, Division of Cardiovascular Medicine Senior Scholar, Center for Clinical Epidemiology and Biostatistics Director, Thalheimer Center for Cardio-Oncology, Director, Penn Center for Quantitative Echocardiography Perelman School of Medicine at the University of Pennsylvania, United States. Dr. David Planchard is a thoracic oncologist and head of Thoracic Group at Gustave Roussy, where he is responsible for coordinating the care of patients with lung cancer, pleural mesothelioma and thymic tumors. He is also Chairman of the International Centre for Thoracic Cancers (CICT), a health cooperation consortium involving Gustave Roussy, Hôpital Marie-Lannelongue and Hôpital Paris Saint-Joseph. Recommended Reading: Changes in Cardiac Function in Patients Receiving Radiation Therapy for Lung Cancer: https://www.jto.org/article/S1556-0864(26)00002-X/fulltext Trastuzumab Deruxtecan in Patients with HER2-Overexpressing Non-Small Cell Lung Cancer: Results From Part 1 of the Open-label, Multicenter, Phase 1b DESTINY-Lung03 Trial: https://www.jto.org/article/S1556-0864(25)03021-7/fulltext JTO May 2026 Issue: https://www.jto.org/issue/S1556-0864(26)X2003-2

12. 

    30 Apr 2026

    JTO Insights: 20 Years of Advances in Basic Science & Radiotherapy

    In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host authors of two articles published in the JTO 20th Anniversary Series. Dr. Michele Carbone, Director of the Thoracic Oncology Program at the University of Hawaii Cancer Center, joins us to discuss their article, “Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact"; and Dr. Jeff Bogart, Distinguished Professor and Chair of Radiation Oncology of SUNY Upstate Medical University, New York, joins to discuss their article, "The Optimization of Radiotherapy in Lung Cancer Treatment: 20 Years of Progress". Recommended Reading: JTO 20th Anniversary Series: https://www.jto.org/content/20thAnniversarySeries "Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact": https://www.jto.org/article/S1556-0864(25)02895-3/fulltext "The Optimization of Radiotherapy in Lung Cancer Treatment: 20 Years of Progress": https://www.jto.org/article/S1556-0864(26)00031-6/fulltext

13. 

    16 Apr 2026

    JTO Insights: April 2026

    In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host authors of two articles published in the Journal of Thoracic Oncology April 2026 issue. Dr. Timothy F. Burns, Professor of Medicine in the Division of Medical Oncology at the Ohio State University Comprehensive Cancer Center, joins us to discuss their article "Efficacy and Safety of Olomorasib in Combination with Pembrolizumab in Treatment of Patients with KRAS G12C-Mutant Advanced NSCLC"; and Dr. Paaladinesh Thavendiranathan of Division of Cardiology, Peter Munk Cardiac Center at the Toronto General Hospital and the Director of the Ted Rogers Program in Cardiotoxicity Prevention joins to discuss their article, "The risk of cardiovascular adverse outcomes in patients with thymoma or thymic carcinoma receiving cancer therapy". Key Topics Covered: • KRAS G12C-mutant NSCLC • Thymoma • Cardiovascular adverse outcomes Recommended Reading: April 2026 JTO Issue: https://www.jto.org/issue/S1556-0864(26)X2002-0 "Efficacy and Safety of Olomorasib in Combination with Pembrolizumab in Treatment of Patients with KRAS G12C-Mutant Advanced NSCLC": https://www.jto.org/article/S1556-0864(25)02936-3/fulltext "The risk of cardiovascular adverse outcomes in patients with thymoma or thymic carcinoma receiving cancer therapy": https://www.jto.org/article/S1556-0864(25)02940-5/fulltext

14. 

    3 Apr 2026

    Introducing JTO Insights: A New Podcast from the Journal of Thoracic Oncology

    Welcome to JTO Insights, the official podcast of the IASLC Journal of Thoracic Oncology (JTO). Hosts Dr. Alex Adjei and Dr. Tom John introduce the new podcast and its mission to deliver concise, accessible insights from the latest JTO research. Each episode features expert discussions with authors, highlighting key studies, clinical implications, and future directions in thoracic oncology. Designed for clinicians, researchers, and healthcare professionals, JTO Insights helps you quickly stay informed on the most impactful advances in the field. Subscribe now so you don’t miss an episode – JTO Insights launces this April 2026 and visit jto.org for full articles and additional research. Co-Hosts: • Alex A. Adjei, MD, PhD, FACP, Editor-in-Chief, Journal of Thoracic Oncology, Chief, Taussig Cancer Institute, Cleveland Clinic, OH, USA • Thomas John, MBBS, PhD, Associate Editor, Journal of Thoracic Oncology, Deputy Director, Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

5.0 / 5

1 ratings

Spotify

5.0 / 5

1 ratings

Contact JTO Insights

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.

Shows with a similar audience

• 

  Lung Cancer Considered

• 

  ASCO Daily News

• 

  Lung Cancer Update

• 

  Journal of Clinical Oncology (JCO) Podcast

• 

  Oncology Brothers

• 

  The Daily